Pulike BioEngineering's 2024 AGM resolutions approved, lawyers affirm legality

Pulike BioEngineering (SSE:603566) successfully held its 2024 Annual General Meeting, with legal counsel Beijing DeHeng Law Firm affirming the legality of the meeting's procedures and resolutions. Shareholders approved key items including the 2024 annual report, board and supervisory reports, financial statements, and profit distribution plans. Notably, a resolution regarding director and supervisor compensation, saw strong approval. Detailed voting results for each resolution are documented in the announcement, confirming shareholder support and adherence to relevant laws, regulations, and the company's articles of association. The lawyers present confirmed that the AGM was conducted in full compliance with Chinese laws.